PDCD1 and cancer: In Turnis’ study, over 75% of mice with MC38 cancer or Sa1N fibrosarcoma were effectively treated with a combination of anti-PD-1 and anti-LAG-3 antibodies, resulting in complete clearance of tumors and prolonged survival [61].